TOP 20

Top 20 Healthcare IPOs of 2024

Shots: Initial Public Offerings (IPOs) serve as a strategic avenue for private healthcare companies to enhance liquidity, secure capital, and strengthen market presence. Beyond fundraising, going public often paves the way for strategic partnerships and expanded industry influence. Galderma led the IPO landscape in 2024, raising a staggering $2.54B, followed by BrightSpring Health Services and…

February 27, 2025

Top 20 Life Sciences Deals of 2024 by Total Deal Value 

Top 20 Life Sciences Deals of 2024 by Total Deal Value Shots: Life Sciences Dealmaking 2024 outlined a new genre of strategies for shaping global healthcare landscapes by targeting emerging technologies and addressing unmet needs In 2024, Arrowhead’s global licensing and commercialization deal with Sarepta Therapeutics for $11.37B ranked first in the list, followed by…

February 20, 2025

20 Emerging Animal Health Companies of India

20 Emerging Animal Health Companies of India Shots: Owing to the agrarian origin and rise in pet ownership trends, the animal healthcare sector in India has witnessed a significant boom In 2023, the animal healthcare market size was valued at $1.9B and is anticipated to grow to $4.3B by 2030, registering a CAGR of 12.3%…

February 10, 2025

Top 20 Biopharma M&A of 2024 by Total Deal Value

Top 20 Biopharma M&A of 2024 by Total Deal Value Shots: Dealmaking in 2024 experienced fluctuations due to regulatory challenges and increasing pressure from the Inflation Reduction Act The highest-value deal of the year was Vertex’s acquisition of Alpine Immune Sciences for $4.9B, followed by Gilead’s acquisition of CymaBay for $4.3B and Lilly’s acquisition of…

February 6, 2025

Top 20 Animal Health Companies of 2024

Shots: The WHO’s One Health policy is driving innovation in animal health, emphasizing the intersection of human, animal, and environmental care The global animal health market, valued at $62.4B in 2023, is expected to grow at a CAGR of 9%, reaching $114B by 2030 PharmaShots presents a comprehensive report on the Top 20 Animal Health Companies of…

December 12, 2024

Top 20 Cell and Gene Therapy Companies of 2024

Shots: Cell and gene therapies provide a promising opportunity to enhance care for unmet healthcare needs. Biopharma companies are actively exploring these therapies across multiple indications to address healthcare gaps in rare and chronic diseases In 2023, the cell and gene therapy market was valued at $18.2B and is projected to grow to $117.46B by…

November 28, 2024

20 Contract Development and Manufacturing Organizations (CDMO) of 2024

Shots: CDMOs are at the forefront of pharmaceutical manufacturing, shaping the industry's growth by meeting the increasing global demand for pharmaceutical products In 2023, the global CDMO market was valued at $224.86B, with projections to reach $465.14B by 2032, demonstrating a CAGR of 8.5% PharmaShots presents a comprehensive report on the 20 Contract Development and…

November 14, 2024

Top 20 Prescription Drugs of 2024

Shots: Driven by an endless pursuit of innovation, the biopharma industry is working tirelessly to bring new-age therapies to patients with serious health conditions and lifestyle-influenced diseases In 2023, the global prescription drug market size was valued at $1162.61B and is anticipated to reach $2151.63B by 2032 registering a CAGR of 7.1 %. Keytruda ranks 1st…

October 31, 2024

Top 20 Countries in Health Innovation in 2024

Top 20 Countries in Health Innovation in 2024 Shots: By leveraging high-quality research, PharmaShots brings a meticulously prepared guide to the Top 20 Countries in Health Innovation Using quantitative and qualitative analysis of several aspects encompassing healthcare innovations, PharmaShots dedicatedly navigated the core focus areas of innovations in healthcare while considering trending practices like the…

October 10, 2024

Top 20 Generic Pharma Companies of 2024

Shots: Known for delivering the same therapeutic benefits as its brand-name counterpart, it won't be an exaggeration to refer to generic drugs as modern-day advocates for health equity In 2022, the global market size of generic drugs was valued at $411.99B and is envisioned to reach $613.34B by 2030 with a CAGR of 5.10%. Sandoz…

September 26, 2024